STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has announced its participation in the upcoming Morgan Stanley Global Healthcare Conference. Mark Singleton, the company's Senior Vice-President and Chief Financial Officer, will engage in a fireside chat on September 10, 2025, at 1:05 p.m. ET.

Investors can access a live webcast of the presentation through the "Investors" section of Bioventus's website at www.bioventus.com, with a replay option available after the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 1 Alert

-2.49% News Effect

On the day this news was published, BVS declined 2.49%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

DURHAM, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Mark Singleton, Bioventus Senior Vice-President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on Wednesday, September 10, 2025, at 1:05 p.m. ET.

A live webcast of the presentation will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Contact:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com


FAQ

When is Bioventus (BVS) presenting at the Morgan Stanley Healthcare Conference 2025?

Bioventus will present on Wednesday, September 10, 2025, at 1:05 p.m. ET through a fireside chat.

Who will represent Bioventus (BVS) at the Morgan Stanley Healthcare Conference?

Mark Singleton, Bioventus's Senior Vice-President and Chief Financial Officer, will represent the company.

How can investors watch the Bioventus (BVS) Morgan Stanley conference presentation?

Investors can watch the live webcast through the "Investors" section of Bioventus's website at www.bioventus.com. A replay will be available after the event.

What topics will Bioventus (BVS) discuss at the Morgan Stanley Healthcare Conference?

Bioventus's CFO will participate in a fireside chat, though specific discussion topics were not disclosed in the announcement.
Bioventus Inc.

NASDAQ:BVS

BVS Rankings

BVS Latest News

BVS Latest SEC Filings

BVS Stock Data

496.97M
59.07M
11.77%
73.52%
2.75%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
DURHAM